NAREB upcoming Consortium meeting...

The 5th NAREB Consortium meeting will be held in Paris, 26-27 September 2016 kindly host by our Coordinator and her Team at the Institut Pasteur's headquarter.

Cluster workshop, Bremen, July 2016

Inscriptions to the workshop "Novel approaches to fight bacteria: From understanding the crossing of membrane barrier to the development of new nanotechnology-based drugs",  co-organised by 4 projects working on the topic: NAREB, PneumoNP, FORMAMP and Translocation are now open!

Join us in Bremen, Germany, from 10-14th July 2016 to communicate and exchange on your research. 

Program is available here.

Register here.

Inscription deadline: 7th June 2016

Flyer Fight bacteria workshop 2016


NAREB: upcoming presentations at meetings

See NAREB progress by visiting posters or assisting to the oral presentations of NAREB partners at the following events:

  • ECCMID 2016, 9-12 April 2016, Amsterdam, NL where Laetitia Lavrain, from Coris, will present a poster 
  • 11th International Symposium on Polymer Therapeutics (ISTP), 23-25 May 2016, Valencia, Spain where where Jesus Martinez de la Fuenta, from Unizar will give a talk entitled "Nanoemulsion-based chitosan nanocapsules as efficient delivery system for bedaquilin antibiotic" and present a poster 
  • ENM meeting on Hydrogel Materials, 9-13 May 2016, Singapore where Laura de Matteis, from UNIZAR, will give a talk entilted  "Hybrid Nanocomposite Hydrogels based on Natural polymers"

NAREB 2nd Annual General meeting, Warsaw, 14-15 March 2016

The NAREB Consortium met in Warsaw for a 2 day meeting. Results and progresses from all ongoing Work Packages were presented and discussed, as well as the next steps of the projects.

Upcoming event organised by CEA (partner 2): SFNano European Nanomedecine Meeting 2015, December 7-9 2015, Grenoble, France

For more information on the meeting: promotion slides and link ...


The NAREB project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 604237.